Leading Public Health Organization Implements ValGenesis Platform

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the market leader in enterprise digital validation, announced that a leading public health organization has gone live with ValGenesis, marking a significant milestone in its mission to strengthen global health research and preparedness.

The organization conducts research focused on addressing infectious diseases and emerging global health challenges, contributing to scientific advancement and improved public health outcomes worldwide.

The implementation establishes a centralized digital validation environment that streamlines workflows, improves visibility across validation activities, and enables teams to apply compliant validation processes consistently across global operations. By replacing fragmented manual processes with a harmonized digital approach, the organization is better positioned to maintain audit readiness and support scalable validation execution.

“I am delighted to announce this successful go-live,” said Steve Reynolds, chief revenue officer at ValGenesis. “This achievement reflects strong collaboration, dedication, and disciplined execution from all teams involved, highlighting our customer’s commitment to operational excellence and innovation in public health, as well as its continued investment in digital transformation to strengthen capabilities and maintain high standards of regulatory compliance.”

About ValGenesis Inc.

ValGenesis, Inc. is the global leader in enterprise digital validation. Serving the life sciences industry for nearly two decades, ValGenesis enables companies to digitize their commissioning, qualification, and validation processes through its AI-enabled ValGenesis Smart GxP™ platform, which includes solutions for risk management, cleaning validation, continued process verification, and CMC development. ValGenesis helps customers worldwide reduce costs, improve compliance, and accelerate innovation. For more information, visit valgenesis.com